VitaSpring Biomedical Co. Ltd. (VSBC)
OTC Markets OTCPK
Price as at 1 Oct 2026, 03:44 UTC. Quotes are delayed.
Fundamentals
Valuation and ratings
VitaSpring Biomedical Co. Ltd. trades at $0.01. We do not hold enough of the inputs to value this company with the confidence the estimate implies, so we publish no fair value for it rather than a number we would not defend.
About VitaSpring Biomedical Co. Ltd.
VitaSpring Biomedical Co. Ltd., a development-stage biomedical company, engages in the research, development, and commercialization of wellness and healthy lifestyle products. It focuses on the development of cell-based medical technologies for use in regenerative medicine, preventive health care, beauty, and anti-aging applications. The company is also involved in the development of cell medical treatment. The company was formerly known as Shemn Corp. and changed its name to VitaSpring Biomedical Co. Ltd. in February 2020. VitaSpring Biomedical Co. Ltd. was incorporated in 2016 and is based in Riverside, California.
Company profile, industry and headcount are as reported by our data provider and can lag a company's own filings by a reporting period. The annual report is the authority.
Common questions
Where does SteadyShares get its VSBC data?
Fundamentals for VSBC come from company filings and exchange data, as listed on OTC Markets OTCPK; institutional ownership comes from SEC 13F filings. The share price shown was last refreshed on 1 Oct 2026, 03:44 UTC and is delayed. Metrics we do not hold are left out of the page rather than estimated.
The full research page for VSBC, with financial statements, ownership detail, peer comparison and alerts, is free inside the app.
Data from company filings, exchange quotes and SEC EDGAR 13F disclosures. Quotes are delayed. Metrics we do not have are left out rather than estimated. Educational information, not financial advice.